Company Filing History:
Years Active: 2023
Title: Kin-Mei Leung: Innovator in Cancer Treatment
Introduction
Kin-Mei Leung is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents for cancer treatment. His innovative work focuses on specific binding members that target the human epidermal growth factor receptor (EGFR).
Latest Patents
Leung holds a patent for EGFR binding molecules. This patent relates to specific binding members that bind to the human epidermal growth factor receptor (EGFR). The specific binding members include an EGFR antigen-binding site, which may be located in two or more structural loops of a CH3 domain. These binding members are anticipated to be useful in treating cancers that express EGFR. He has 1 patent to his name.
Career Highlights
Kin-Mei Leung is currently associated with F-star Therapeutics, Inc., where he continues to advance his research in the field of cancer therapeutics. His work is pivotal in developing new treatment options for patients suffering from various forms of cancer.
Collaborations
Some of his notable coworkers include Mihriban Tuna and Haijun Sun. Their collaborative efforts contribute to the innovative research environment at F-star Therapeutics, Inc.
Conclusion
Kin-Mei Leung is a distinguished inventor whose work on EGFR binding molecules holds promise for cancer treatment. His contributions to biotechnology are significant and continue to impact the field positively.